Publication Type:

Journal Article

Source:

Fooyin Journal of Health Sciences, Volume 2, Number 3-4, p.109-112 (2010)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-79951667868&partnerID=40&md5=b73424cf521f89390701dacafb5454cf

Keywords:

abnormal urine composition, adult, alkaline phosphatase, alkaline phosphatase blood level, article, bone scintiscanning, case report, excision, fibroblast growth factor 23, hemangiopericytoma, histopathology, human, hyperphosphaturia, limb weakness, lumbar canal stenosis, male, medronate technetium tc 99m, metabolic bone disease, neuroimaging, nuclear magnetic resonance imaging, Nuclear Medicine, oncogenic osteomalacia, osteoporosis, pelvis radiography, priority journal, tibial hemangiopericytoma, vertebral canal stenosis

Abstract:

Oncogenic osteomalacia is a rare metabolic bone disease characterized by hypophosphatemia, renal phosphate wasting, suppressed 1,25-dihydroxyvitamin D production, and osteomalacia. A phosphaturic factor secreted by these tumors is responsible for the symptomatology. The main mechanism underlying this disease condition is an over expression of fibroblast growth factor 23 (FGF-23). Complete excision of these tumors facilitates successful reversal of the problem. We report the case of a patient who was crippled and on extensive investigation revealed an oncogenic osteomalacia with tumor focus in right tibia. The tumor was identified as a mesenchymal tumor, i.e. hemangiopericytoma. Tumor excision alleviated patient symptoms with rapid symptomatic and biochemical improvement. © 2010 Fooyin University.

Notes:

cited By (since 1996)0

Cite this Research Publication

P. Sundaram, Palaniswamy, S. S., George, S., Harish, V., and Rai, J. K., “Tibial Hemangiopericytoma Diagnosed by Nuclear Medicine Techniques”, Fooyin Journal of Health Sciences, vol. 2, pp. 109-112, 2010.